Literature DB >> 4186953

Death after intrathecal methotrexate.

E H Back.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4186953     DOI： 10.1016/s0140-6736(69)90554-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Encephalopathy in acute leukaemia associated with methotrexate therapy.

Authors:  H E Kay; P J Knapton; J P O'Sullivan; D G Wells; R F Harris; E M Innes; J Stuart; F C Schwartz; E N Thompson
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

2.  Cytostatic treatment of meningeal blastoses.

Authors:  P Engelhardt; R Lorenz
Journal:  J Neurol       Date:  1979-01-05       Impact factor: 4.849

3.  Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of literature.

Authors:  W Grisold; D Lutz; D Wolf
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

4.  Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate.

Authors:  W Boogerd; J J vd Sande; D Moffie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

5.  Calcified cerebral necrosis following ALL therapy.

Authors:  K M Müller; R Menne; K D Bachmann; H Gröbe
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

6.  Acute reversible neurological deficit following intrathecal chemotherapy.

Authors:  H Dunkelman; H M Earl; C Twelves
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Development of meningeal leukemia in rats by intracerebral or intrameningeal inoculation of the acute transplantable leukemia L 5222.

Authors:  H H Fiebig; W J Zeller; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30

8.  Combined effects of radiation and methotrexate on the cells of the rat subependymal plate.

Authors:  A D Morris; J W Hopewell
Journal:  J R Soc Med       Date:  1983-10       Impact factor: 18.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.